Muhammad Umair Mushtaq

18PUBLICATIONS
44CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)NanomedicineMedical mycologyRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Dec 11, 2025
Comparison of Standard of Care with or Without a PD-1/PD-L-1 Inhibitor for the Treatment of Multiple Myeloma: A Systematic Review and Meta-Analysis of Phase II and III Randomized Controlled Trials.

Zain Alsaddi, Osama Younis, Ghena Khasawneh

|Sep 26, 2025
CAR-T Access Disparities for Multiple Myeloma in the Midwest: A Social Determinants of Health Perspective.

Michael Weise, Shebli Atrash, Briha Ansari

|Jun 04, 2025
Global Access to Multiple Myeloma Therapies.

|May 09, 2025
Reduced dose fludarabine and cyclophosphamide lymphodepletion before tumor-infiltrating lymphocyte therapy in melanoma.

Muhammad Umair Mushtaq, Haitham Abdelhakim, Luke Selby

|May 05, 2025
Attitudes and perspectives of oncologists about measurable residual disease testing in multiple myeloma: initiative for standardizing guidelines.

Aqeeb Ur Rehman, Fathima Shehnaz Ayoobkhan, Moazzam Shahzad

|Jun 07, 2024
Comparison of biosimilar filgrastim and originator filgrastim for peripheral blood stem cell mobilization for allogeneic hematopoietic stem cell transplantation.

Moazzam Shahzad, Muhammad Kashif Amin, Polina Bellman

Pageof 3

Frequent Collaborators

8 joint publications

Moazzam Shahzad

6 joint publications

Al-Ola Abdallah

5 joint publications

Muhammad Kashif Amin

5 joint publications

Joseph P McGuirk